As a negative acute-phase reactant, serum Alb levels decrease in response to systemic inflammation, and hypoalbuminemia (commonly defined as <3.5 g/dL) has emerged as a significant prognostic marker in a variety of conditions, including stroke (8, 28, 29). The gene discussed is ALB; the disease is stroke disorder.